High Risk Stocks To Buy 2017 May 2026

: Stocks like Freeport-McMoRan (FCX) and Cameco (CCJ) were considered high-risk due to volatile commodity prices. FCX, in particular, was viewed as a speculative "survival" play as it wrestled with high debt levels relative to cash flow.

: Expectations of tax cuts and increased infrastructure support under the new U.S. administration provided a tailwind for industrial and homebuilding stocks like Boeing (BA) and D.R. Horton (DHI) .

: A top performer in the S&P 500 with a 132% gain . High risk stemmed from a major corporate overhaul, where the company shed clean energy assets and cut costs under pressure from activist investors. high risk stocks to buy 2017

: 2017 favored growth investors; U.S. growth stocks returned roughly 29.59%, more than double the 13.19% return of value stocks. 10 High-Risk, High-Reward Stocks to Buy for 2017

For investors in 2017, the "high-risk, high-reward" segment of the market was defined by a strong rebound in energy, explosive breakthroughs in biotechnology, and the rising dominance of high-growth technology. While the broader market saw a lack of volatility, with the S&P 500 rising roughly 20% and the Nasdaq nearly 30%, these specific sectors offered triple-digit gains for those willing to stomach higher volatility. : Stocks like Freeport-McMoRan (FCX) and Cameco (CCJ)

: This biotechnology firm was a standout, posting a 426% return in 2017. Its growth was driven by positive clinical trial results for its cholesterol-reducing drug candidate.

The following stocks represented some of the most successful speculative plays for the year: High risk stemmed from a major corporate overhaul,

: The maker of Invisalign benefited from a near-monopoly on invisible braces, seeing a 131% increase as it expanded its training to thousands of dentists globally.